Novo Nordisk A/S (NONOF)
122.81
-1.34
(-1.08%)
USD |
OTCM |
Apr 18, 15:32
Novo Nordisk Max Drawdown (5Y): 24.80% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 24.80% |
| February 29, 2024 | 24.80% |
| January 31, 2024 | 24.80% |
| December 31, 2023 | 24.80% |
| November 30, 2023 | 24.80% |
| October 31, 2023 | 24.80% |
| September 30, 2023 | 24.80% |
| August 31, 2023 | 24.80% |
| July 31, 2023 | 27.40% |
| June 30, 2023 | 27.40% |
| May 31, 2023 | 27.40% |
| April 30, 2023 | 27.40% |
| March 31, 2023 | 27.40% |
| February 28, 2023 | 27.40% |
| January 31, 2023 | 27.40% |
| December 31, 2022 | 27.40% |
| November 30, 2022 | 27.40% |
| October 31, 2022 | 27.40% |
| September 30, 2022 | 27.40% |
| August 31, 2022 | 27.40% |
| July 31, 2022 | 27.40% |
| June 30, 2022 | 27.40% |
| May 31, 2022 | 27.40% |
| April 30, 2022 | 27.61% |
| March 31, 2022 | 27.61% |
| Date | Value |
|---|---|
| February 28, 2022 | 31.13% |
| January 31, 2022 | 37.84% |
| December 31, 2021 | 42.96% |
| November 30, 2021 | 42.96% |
| October 31, 2021 | 42.96% |
| September 30, 2021 | 42.96% |
| August 31, 2021 | 44.86% |
| July 31, 2021 | 44.86% |
| June 30, 2021 | 44.86% |
| May 31, 2021 | 44.86% |
| April 30, 2021 | 44.86% |
| March 31, 2021 | 44.86% |
| February 28, 2021 | 44.86% |
| January 31, 2021 | 44.86% |
| December 31, 2020 | 44.86% |
| November 30, 2020 | 44.86% |
| October 31, 2020 | 44.86% |
| September 30, 2020 | 44.86% |
| August 31, 2020 | 44.86% |
| July 31, 2020 | 44.86% |
| June 30, 2020 | 44.86% |
| May 31, 2020 | 44.86% |
| April 30, 2020 | 44.86% |
| March 31, 2020 | 44.86% |
| February 29, 2020 | 44.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
24.80%
Minimum
Aug 2023
44.86%
Maximum
Apr 2019
36.77%
Average
42.96%
Median
Sep 2021
Max Drawdown (5Y) Benchmarks
| Eli Lilly and Co | 22.48% |
| Amgen Inc | 24.86% |
| Pfizer Inc | 53.93% |
| AstraZeneca PLC | 24.93% |